Insomnia Pharmacological Treatment and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Insomnia Pharmacological Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Insomnia Pharmacological Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Insomnia Pharmacological Treatment Overall Market Size
2.1 Global Insomnia Pharmacological Treatment Market Size: 2021 VS 2028
2.2 Global Insomnia Pharmacological Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Insomnia Pharmacological Treatment Players in Global Market
3.2 Top Global Insomnia Pharmacological Treatment Companies Ranked by Revenue
3.3 Global Insomnia Pharmacological Treatment Revenue by Companies
3.4 Top 3 and Top 5 Insomnia Pharmacological Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Insomnia Pharmacological Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Insomnia Pharmacological Treatment Players in Global Market
3.6.1 List of Global Tier 1 Insomnia Pharmacological Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Insomnia Pharmacological Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Insomnia Pharmacological Treatment Market Size Markets, 2021 & 2028
4.1.2 Prescription Sleep Aids
4.1.3 Over-the-Counter Sleep Aids
4.2 By Type - Global Insomnia Pharmacological Treatment Revenue & Forecasts
4.2.1 By Type - Global Insomnia Pharmacological Treatment Revenue, 2017-2022
4.2.2 By Type - Global Insomnia Pharmacological Treatment Revenue, 2023-2028
4.2.3 By Type - Global Insomnia Pharmacological Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Insomnia Pharmacological Treatment Market Size, 2021 & 2028
5.1.2 Homecare
5.1.3 Clinic
5.1.4 Hospital
5.2 By Application - Global Insomnia Pharmacological Treatment Revenue & Forecasts
5.2.1 By Application - Global Insomnia Pharmacological Treatment Revenue, 2017-2022
5.2.2 By Application - Global Insomnia Pharmacological Treatment Revenue, 2023-2028
5.2.3 By Application - Global Insomnia Pharmacological Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Insomnia Pharmacological Treatment Market Size, 2021 & 2028
6.2 By Region - Global Insomnia Pharmacological Treatment Revenue & Forecasts
6.2.1 By Region - Global Insomnia Pharmacological Treatment Revenue, 2017-2022
6.2.2 By Region - Global Insomnia Pharmacological Treatment Revenue, 2023-2028
6.2.3 By Region - Global Insomnia Pharmacological Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Insomnia Pharmacological Treatment Revenue, 2017-2028
6.3.2 US Insomnia Pharmacological Treatment Market Size, 2017-2028
6.3.3 Canada Insomnia Pharmacological Treatment Market Size, 2017-2028
6.3.4 Mexico Insomnia Pharmacological Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Insomnia Pharmacological Treatment Revenue, 2017-2028
6.4.2 Germany Insomnia Pharmacological Treatment Market Size, 2017-2028
6.4.3 France Insomnia Pharmacological Treatment Market Size, 2017-2028
6.4.4 U.K. Insomnia Pharmacological Treatment Market Size, 2017-2028
6.4.5 Italy Insomnia Pharmacological Treatment Market Size, 2017-2028
6.4.6 Russia Insomnia Pharmacological Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Insomnia Pharmacological Treatment Market Size, 2017-2028
6.4.8 Benelux Insomnia Pharmacological Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Insomnia Pharmacological Treatment Revenue, 2017-2028
6.5.2 China Insomnia Pharmacological Treatment Market Size, 2017-2028
6.5.3 Japan Insomnia Pharmacological Treatment Market Size, 2017-2028
6.5.4 South Korea Insomnia Pharmacological Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Insomnia Pharmacological Treatment Market Size, 2017-2028
6.5.6 India Insomnia Pharmacological Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Insomnia Pharmacological Treatment Revenue, 2017-2028
6.6.2 Brazil Insomnia Pharmacological Treatment Market Size, 2017-2028
6.6.3 Argentina Insomnia Pharmacological Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Insomnia Pharmacological Treatment Revenue, 2017-2028
6.7.2 Turkey Insomnia Pharmacological Treatment Market Size, 2017-2028
6.7.3 Israel Insomnia Pharmacological Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Insomnia Pharmacological Treatment Market Size, 2017-2028
6.7.5 UAE Insomnia Pharmacological Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Eisai, Co. Ltd. (Japan)
7.1.1 Eisai, Co. Ltd. (Japan) Corporate Summary
7.1.2 Eisai, Co. Ltd. (Japan) Business Overview
7.1.3 Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Major Product Offerings
7.1.4 Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Revenue in Global Market (2017-2022)
7.1.5 Eisai, Co. Ltd. (Japan) Key News
7.2 Merck & Co., Inc (US)
7.2.1 Merck & Co., Inc (US) Corporate Summary
7.2.2 Merck & Co., Inc (US) Business Overview
7.2.3 Merck & Co., Inc (US) Insomnia Pharmacological Treatment Major Product Offerings
7.2.4 Merck & Co., Inc (US) Insomnia Pharmacological Treatment Revenue in Global Market (2017-2022)
7.2.5 Merck & Co., Inc (US) Key News
7.3 Meda Consumer Healthcare Inc (US)
7.3.1 Meda Consumer Healthcare Inc (US) Corporate Summary
7.3.2 Meda Consumer Healthcare Inc (US) Business Overview
7.3.3 Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Major Product Offerings
7.3.4 Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Revenue in Global Market (2017-2022)
7.3.5 Meda Consumer Healthcare Inc (US) Key News
7.4 Pfizer, Inc (US)
7.4.1 Pfizer, Inc (US) Corporate Summary
7.4.2 Pfizer, Inc (US) Business Overview
7.4.3 Pfizer, Inc (US) Insomnia Pharmacological Treatment Major Product Offerings
7.4.4 Pfizer, Inc (US) Insomnia Pharmacological Treatment Revenue in Global Market (2017-2022)
7.4.5 Pfizer, Inc (US) Key News
7.5 Sanofi (France)
7.5.1 Sanofi (France) Corporate Summary
7.5.2 Sanofi (France) Business Overview
7.5.3 Sanofi (France) Insomnia Pharmacological Treatment Major Product Offerings
7.5.4 Sanofi (France) Insomnia Pharmacological Treatment Revenue in Global Market (2017-2022)
7.5.5 Sanofi (France) Key News
7.6 Takeda Pharmaceutical Company Ltd. (Japan)
7.6.1 Takeda Pharmaceutical Company Ltd. (Japan) Corporate Summary
7.6.2 Takeda Pharmaceutical Company Ltd. (Japan) Business Overview
7.6.3 Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Major Product Offerings
7.6.4 Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Revenue in Global Market (2017-2022)
7.6.5 Takeda Pharmaceutical Company Ltd. (Japan) Key News
7.7 Pernix Therapeutics (US)
7.7.1 Pernix Therapeutics (US) Corporate Summary
7.7.2 Pernix Therapeutics (US) Business Overview
7.7.3 Pernix Therapeutics (US) Insomnia Pharmacological Treatment Major Product Offerings
7.7.4 Pernix Therapeutics (US) Insomnia Pharmacological Treatment Revenue in Global Market (2017-2022)
7.7.5 Pernix Therapeutics (US) Key News
7.8 Purdue Pharma L.P (US)
7.8.1 Purdue Pharma L.P (US) Corporate Summary
7.8.2 Purdue Pharma L.P (US) Business Overview
7.8.3 Purdue Pharma L.P (US) Insomnia Pharmacological Treatment Major Product Offerings
7.8.4 Purdue Pharma L.P (US) Insomnia Pharmacological Treatment Revenue in Global Market (2017-2022)
7.8.5 Purdue Pharma L.P (US) Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Insomnia Pharmacological Treatment Market Opportunities & Trends in Global Market
Table 2. Insomnia Pharmacological Treatment Market Drivers in Global Market
Table 3. Insomnia Pharmacological Treatment Market Restraints in Global Market
Table 4. Key Players of Insomnia Pharmacological Treatment in Global Market
Table 5. Top Insomnia Pharmacological Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Insomnia Pharmacological Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Insomnia Pharmacological Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Insomnia Pharmacological Treatment Product Type
Table 9. List of Global Tier 1 Insomnia Pharmacological Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Insomnia Pharmacological Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Insomnia Pharmacological Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Insomnia Pharmacological Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Insomnia Pharmacological Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Insomnia Pharmacological Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Insomnia Pharmacological Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Insomnia Pharmacological Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Eisai, Co. Ltd. (Japan) Corporate Summary
Table 31. Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Product Offerings
Table 32. Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Merck & Co., Inc (US) Corporate Summary
Table 34. Merck & Co., Inc (US) Insomnia Pharmacological Treatment Product Offerings
Table 35. Merck & Co., Inc (US) Insomnia Pharmacological Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Meda Consumer Healthcare Inc (US) Corporate Summary
Table 37. Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Product Offerings
Table 38. Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Pfizer, Inc (US) Corporate Summary
Table 40. Pfizer, Inc (US) Insomnia Pharmacological Treatment Product Offerings
Table 41. Pfizer, Inc (US) Insomnia Pharmacological Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Sanofi (France) Corporate Summary
Table 43. Sanofi (France) Insomnia Pharmacological Treatment Product Offerings
Table 44. Sanofi (France) Insomnia Pharmacological Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Takeda Pharmaceutical Company Ltd. (Japan) Corporate Summary
Table 46. Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Product Offerings
Table 47. Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Pernix Therapeutics (US) Corporate Summary
Table 49. Pernix Therapeutics (US) Insomnia Pharmacological Treatment Product Offerings
Table 50. Pernix Therapeutics (US) Insomnia Pharmacological Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Purdue Pharma L.P (US) Corporate Summary
Table 52. Purdue Pharma L.P (US) Insomnia Pharmacological Treatment Product Offerings
Table 53. Purdue Pharma L.P (US) Insomnia Pharmacological Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Insomnia Pharmacological Treatment Segment by Type in 2021
Figure 2. Insomnia Pharmacological Treatment Segment by Application in 2021
Figure 3. Global Insomnia Pharmacological Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Insomnia Pharmacological Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Insomnia Pharmacological Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Insomnia Pharmacological Treatment Revenue in 2021
Figure 8. By Type - Global Insomnia Pharmacological Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Insomnia Pharmacological Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Insomnia Pharmacological Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Insomnia Pharmacological Treatment Revenue Market Share, 2017-2028
Figure 12. US Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Insomnia Pharmacological Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Insomnia Pharmacological Treatment Revenue Market Share, 2017-2028
Figure 24. China Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Insomnia Pharmacological Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Insomnia Pharmacological Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Insomnia Pharmacological Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck & Co., Inc (US) Insomnia Pharmacological Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pfizer, Inc (US) Insomnia Pharmacological Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sanofi (France) Insomnia Pharmacological Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Pernix Therapeutics (US) Insomnia Pharmacological Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Purdue Pharma L.P (US) Insomnia Pharmacological Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
